• Mashup Score: 0
    Diabetes 2023 - 9 month(s) ago

    Read our special collection of journal articles, published in 2022–2023, focused on diabetes! Curation of the collection was guided by Altmetric Attention Scores and Featured Article designations.

    Tweet Tweets with this article
    • What did you think of our Thematic Issue on #Diabetes @EndoSocJournals? Reread and share our collection of journal articles with curations from #EndocrineReviews, #Endocrinology, #JES, and #JCEM: https://t.co/CHpknIyt7V https://t.co/7rIcylPw1w

  • Mashup Score: 0

    More than half of adults with acromegaly receiving the somatostatin receptor ligand pasireotide achieved normal insulin-like growth factor I levels, according to data from a long-term real-world study. “To our knowledge, this analysis, based on our single-center results, reports the longest follow-up of patients with acromegaly treated with pasireotide to date,” Mônica Gadelha,

    Tweet Tweets with this article
    • #ICYMI: "Importantly, for patients who initiated antidiabetic medication during treatment with pasireotide, medication was no longer required and glucose and HbA1c levels were normalized." @gadelha_monica @EndoMedia #JCEM https://t.co/UtHyHTjpKX

  • Mashup Score: 0

    Despite some observational evidence, drinking light or moderate amounts of alcohol may not reduce one’s risk for type 2 diabetes or obesity, according to findings published in The Journal of Clinical Endocrinology & Metabolism. In observational data from the UK Biobank, adults who consumed fewer than 3.5 drinks per week had a reduced likelihood for developing obesity and type 2 diabetes

    Tweet Tweets with this article
    • ICYMI: "Heavy drinking could lead to increased measures of #obesity as well as increased risk of type 2 #diabetes.” #JCEM @TianyuanLu1 @EndoMedia https://t.co/7mNL7dVNlj

  • Mashup Score: 1

    Despite some observational evidence, drinking light or moderate amounts of alcohol may not reduce one’s risk for type 2 diabetes or obesity, according to findings published in The Journal of Clinical Endocrinology & Metabolism. In observational data from the UK Biobank, adults who consumed fewer than 3.5 drinks per week had a reduced likelihood for developing obesity and type 2 diabetes

    Tweet Tweets with this article
    • #ICYMI: "Our study shows that even light to moderate alcohol consumption (no more than one standard drink per day) does not protect against #obesity and type 2 #diabetes." #JCEM @TianyuanLu1 @EndoMedia https://t.co/7mNL7dVNlj

  • Mashup Score: 0

    Despite some observational evidence, drinking light or moderate amounts of alcohol may not reduce one’s risk for type 2 diabetes or obesity, according to findings published in The Journal of Clinical Endocrinology & Metabolism. In observational data from the UK Biobank, adults who consumed fewer than 3.5 drinks per week had a reduced likelihood for developing obesity and type 2 diabetes

    Tweet Tweets with this article
    • Drinking light or moderate amount of alcohol does not lower the risk for type 2 #diabetes or #obesity, according to findings from Mendelian randomization analyses published in #JCEM. @TianyuanLu1 @EndoMedia https://t.co/7mNL7dVNlj

  • Mashup Score: 1

    June 2023 Read our special collection of journal articles, published in 2022–2023, focused on bone research! Curation of the collection was guided by Altmetric

    Tweet Tweets with this article
    • What did you think of our Thematic Issue on #bone research @EndoSocJournals? Reread and share our collection of journal articles with curations from #EndocrineReviews, #Endocrinology, #JES, and #JCEM: https://t.co/c1DFqQMlkv https://t.co/zaS0fNdVwV

  • Mashup Score: 0
    Become a Member - 11 month(s) ago

    Join our global community of 18,000 endocrine researchers and practitioners to improve human health worldwide. ​

    Tweet Tweets with this article
    • Become a member to enjoy the many benefits of publishing in our journals, #JES, #JCEM, #Endocrinology, #EndocrineReviews, and #JCEMCaseReports from now until December 2024: https://t.co/IufWdQrqkz https://t.co/anjeR2BSFc